Shilei Ding
- Virology top 0.5%
- HIV Research and Treatment 42
- Immunology top 2%
- Immune Cell Function and Interaction 23
- interferon and immune responses 10
- Infectious Diseases top 2%
- HIV/AIDS drug development and treatment 17
- SARS-CoV-2 and COVID-19 Research 14
- COVID-19 Clinical Research Studies 8
- SARS-CoV-2 detection and testing 6
- Epidemiology top 10%
- Hepatology top 10%
-
- Monoclonal and Polyclonal Antibodies Research 11
- Co-authors
- Andrés FinziQinghua PanShan‐Lu LiuChen LiangJonathan RichardJérémie PrévostMinghua LiFei Guo
- Partner nations
- CanadaUnited StatesChina
In The Last Decade
Shilei Ding
59 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 74
- Virology 1.2k
- Immunology 1.1k
- Infectious Diseases 858
- Epidemiology 455
- Hepatology 88
Countries citing papers authored by Shilei Ding
This map shows the geographic impact of Shilei Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shilei Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shilei Ding more than expected).
Fields of papers citing papers by Shilei Ding
This network shows the impact of papers produced by Shilei Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shilei Ding. The network helps show where Shilei Ding may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shilei Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 20 | |
| 4 | 2023 | 10 | |
| 5 | 2023 | 16 | |
| 6 | 2023 | 7 | |
| 7 | 2023 | 4 | |
| 8 | 2023 | 11 | |
| 9 | 2023 | 4 | |
| 10 | 2022 | 9 | |
| 11 | 2022 | 4 | |
| 12 | 2022 | 48 | |
| 13 | 2020 | 13 | |
| 14 | 2019 | 10 | |
| 15 | 2019 | 26 | |
| 16 | 2016 | 21 | |
| 17 | 2015 | 29 | |
| 18 | 2014 | 33 | |
| 19 | 2014 | 33 | |
| 20 | 2013 | 265 |
About Shilei Ding
Shilei Ding is a scholar working on Virology, Infectious Diseases and Immunology, having authored 61 papers that have together received 2.0k indexed citations. Recurring topics across this work include HIV Research and Treatment (42 papers), Immune Cell Function and Interaction (23 papers), HIV/AIDS drug development and treatment (17 papers), SARS-CoV-2 and COVID-19 Research (14 papers), Monoclonal and Polyclonal Antibodies Research (11 papers), interferon and immune responses (10 papers), COVID-19 Clinical Research Studies (8 papers) and SARS-CoV-2 detection and testing (6 papers). The work is most often cited by research in Virology (1.2k citations), Immunology (1.1k citations) and Infectious Diseases (858 citations). Shilei Ding has collaborated with scholars based in Canada, United States and China. Frequent co-authors include Andrés Finzi, Qinghua Pan, Shan‐Lu Liu, Chen Liang, Chen Liang, Jonathan Richard, Jérémie Prévost, Minghua Li, Fei Guo and Jin Qian. Their work appears in journals such as Journal of Virology, Viruses, mBio, Virology and Cell Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.